Characterizing the role of endothelin-1 in the progression of cardiac hypertrophy in aryl hydrocarbon receptor (AhR) null mice

Toxicology and Applied Pharmacology

Volumn 212, Issue 2, 2006, Pages 127-135

  Lund, Amie K ^a   Goens, M Beth ^b   Nuñez, Bethany A ^a   Walker, Mary K ^a,b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Aryl hydrocarbon receptor (AhR); BQ 123; Cardiac fibrosis; Cardiac hypertrophy; Endothelin 1; Hypertension

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; ATRIAL NATRIURETIC FACTOR; COLLAGEN TYPE 1; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; MESSENGER RNA; MYOSIN HEAVY CHAIN BETA; OSTEOPONTIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CATHETERIZATION; CONSCIOUSNESS; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; HEART HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART WEIGHT; HISTOPATHOLOGY; MEAN ARTERIAL PRESSURE; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN EXPRESSION; WILD TYPE;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; CARDIOMEGALY; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ENDOTHELIN-1; FIBROSIS; HYPERTROPHY, LEFT VENTRICULAR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, CARDIAC; ORGAN SIZE; PEPTIDES, CYCLIC; RECEPTOR, ENDOTHELIN A; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER;

ANIMALIA;

EID: 33645794016     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2005.07.005     Document Type: Article

References (32)

1. Ashizawa N., Graf K., Do Y.S., Nunohiro T., Giachelli C.M., Meehan W.P., Tuan T.L., and Hsueh W.A. Osteopontin is produced by rat cardiac fibroblasts and mediates angiotensin II-induced DNA synthesis and collagen gel contraction. J. Clin. Invest. 98 (1996) 2218-2227
2. Campia U., Cardillo C., and Panza J.A. Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients. Circulation 109 (2004) 3191-3195
3. A receptor antagonism does not attenuate angiotensin II-induced cardiac hypertrophy in vivo in rats. Clin. Exp. Pharmacol. Physiol. 30 (2003) 278-283
4. A receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats. Hypertension 33 (1999) 954-960
5. El-Gharbawy A.H., Kotchen J.M., Grim C.E., Kaldunski M., Hoffmann R.G., Pausova Z., Gaudet D., Gossard F., Hamet P., and Kotchen T.A. Predictors of target organ damage in hypertensive blacks and whites. Hypertension 38 (2001) 761-766
6. Ergul S., Parish D.C., Puett D., and Ergul A. Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension. Hypertension 28 (1996) 652-655
7. Fernandez-Salguero P.M., Ward J.M., Sundberg J.P., and Gonzales F.J. Lesions of Aryl-hydrocarbon receptor-deficient mice. Vet. Pathol. 34 (1997) 605-614
8. Giachelli C.M., Schwartz S.M., and Liaw L. Molecular and cellular biology of osteopontin: potential role in cardiovascular disease. Trends Cardiovasc. Med. 5 (1995) 88-95
9. Graf K., Do Y.S., Ashizawa N., Meehan W.P., Giachelli C.M., Marboe C.C., Fleck E., and Hsueh W.A. Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation 96 (1997) 3063-3071
10. Gu Y.Z., Hogenesch J.B., and Bradfield C.A. The PAS SUPERFAMILY: sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 519-561
11. Guarda E., Katwa L.C., Myers P.R., Tyagi S., and Weber K. Effects of endothelin on collagen turnover in cardiac fibroblasts. Cardiovasc. Res. 27 (1993) 2130-2134
12. A receptor in cultured human fibroblasts. Cell. Physiol. Biochem. 14 (2004) 285-292
13. Hua L., Li C., Xia D., Qu P., Li Z., Zhang W., and Feng X. Relationship between hypertensive LVH and levels of endothelin and nitric oxide. Hypertens Res. 23 (2000) 377-380
14. A receptor antagonist blocks cardiac hypertrophy provoked by pressure overload. Circulation 89 (1994) 2198-2203
15. Kawaguchi H., Sawa H., and Yasuda H. Endothelin stimulates angiotensin I to angiotensin II conversion in cultured pulmonary artery endothelial cells. J. Mol. Cell. Cardiol. 22 8 (1990) 839-842
16. A receptor knockout mice have normal cardiac function and an unaltered hypertrophic response to angiotensin II and isoproterenol. Mol. Cell. Biol. 23 (2003) 8226-8232
17. B receptors, and ECE and distribution of endothelin-1 in failing rat heart. Am. J. Physiol. 276 (1999) H1197-H1206
18. Liao Y., Copper R.S., McGee D.L., Mensah G.A., and Ghali J.K. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among Black adults. JAMA 273 (1995) 1592-1597
19. Lund A.K., Goens M.B., Kanagy N.L., and Walker M.K. Cardiac hypertrophy in Aryl hydrocarbon null mice is correlated with elevated angiotensin II, endothelin-1 and mean arterial blood pressure. Toxicol. Appl. Pharmacol. 193 (2003) 177-187
20. Mattson D.L. Long-term measurement of arterial blood pressure in conscious mice. Am. J. Physiol. 274 (1998) R564-R570
21. Matsui Y., Jia N., Okamoto H., Kon S., Onozuka H., Akino M., Liu L., Morimoto J., Rilttling S.R., Denhardt D., Kitabatake A., and Uede T. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy. Hypertension 43 (2004) 1195-1201
22. Rodriguez C.J., Sciacca R.R., Diez-Roux A.V., Boden-Albala B., Sacco R.L., Homma S., and DiTullio M.R. Relation between socioeconomic status, race-ethnicity, and left ventricular mass: The Northern Manhattan Study. Hypertension 43 (2004) 775-779
23. Rothermond L., Kreutz R., Kossmehl P., Fredersdorf S., Shakibaie M., Schulze-Tanzil G., Paul M., and Grimm D. Early onset of chondroitin sulfate and osteopontin expression in angiotensin II-dependent left ventricular hypertrophy. Am. J. Hypertens 15 (2002) 644-652
24. Sakai S., Miyauchi T., Kobayashi M., Yamaguchi I., Goto K., and Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 384 (1996) 353-355
25. Seta Y., Kanda T., Yokoyama T., Arai M., Sekiguchi K., Tanaka T., Kobayashi I., Kurabayashi M., and Nagai R. Therapy with the nonpeptide endothelin receptor antagonist 97-139 in a murine model of congestive heart failure. Jpn. Heart J. 41 (2000) 79-85
26. Song J., Claget-Dame M., Peterson R.E., Hahn M.E., Westler W.M., Sicinski R.R., and DeLuca H. A ligand for the aryl hydrocarbon receptor isolated from lung. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 14694-14699
27. Thackaberry E.A., Smith S.M., Gabaldon D.M., and Walker M.K. Aryl hydrocarbon receptor null mice develop cardiac hypertrophy and increased hypoxia-inducible factor-1α in the absence of cardiac hypoxia. Cardiovasc. Toxicol. 2 (2002) 263-273
28. Vasquez A., Atallah-Yunes N., Smith F.C., You X., Chase S.E., Silverstone A.E., and Vikstrom K.L. A role for the aryl hydrocarbon receptor in cardiac physiology and function as demonstrated by AhR knockout mice. Cardiovasc. Toxicol. 3 (2003) 153-163
29. Wong J.M., Okey A.B., and Haper P.A. Human aryl hydrocarbon receptor polymorphisms that result in loss of CYP1A1 induction. Biochem. Biophys. Res. Commun. 288 (2001) 990-996
30. Xia Y., and Karmazyn M. Obligatory role for endogenous endothelin in mediating hypertrophic effects of phenylphrine and angiotensin II in neonatal rat ventricular myocytes: evidence for two distinct mechanisms for endothelin regulation. J. Pharmacol. Exp. Ther. 310 (2004) 43-51
31. Yamauchi-Kohno R., Miyauchi T., Hoshino T., Kobayashi T., Aihara H., Sakai S., Yabana K., Goto K., Sugishita Y., and Murata S. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: increase in endothelin-1 production in the heart and the beneficial effects of endothelin-A receptor antagonist on survival and cardiac function. Circulation 99 (1999) 2171-2716
32. Yang L.L., Gros R., Kabir M.G., Sadi A., Gotlieb A.I., Husain M., and Stewart D.J. Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice. Circulation 109 (2004) 255-261